10 likes | 170 Views
Mipomersen as add-on therapy in FH Mean Percent Change from Baseline to Primary Efficacy Timepoint for LDL-C. Placebo ISIS 301012 200 mg. Mean Percent Change in LDL-C. Stein EA, Dufour R, Gagne C, et al. Circulation. 2012 Oct 11.
E N D
Mipomersen as add-on therapy in FHMean Percent Change from Baseline to Primary Efficacy Timepointfor LDL-C Placebo ISIS 301012 200 mg Mean Percent Change in LDL-C Stein EA, Dufour R, Gagne C, et al. Circulation. 2012 Oct 11